Annual CFF
$40.45 M
+$25.56 M+171.71%
December 31, 2023
Summary
- As of February 7, 2025, CKPT annual cash flow from financing activities is $40.45 million, with the most recent change of +$25.56 million (+171.71%) on December 31, 2023.
- During the last 3 years, CKPT annual CFF has risen by +$9.20 million (+29.46%).
- CKPT annual CFF is now -25.16% below its all-time high of $54.05 million, reached on December 31, 2015.
Performance
CKPT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$10.96 M
+$11.01 M+22024.00%
September 30, 2024
Summary
- As of February 7, 2025, CKPT quarterly cash flow from financing activities is $10.96 million, with the most recent change of +$11.01 million (+22024.00%) on September 30, 2024.
- Over the past year, CKPT quarterly CFF has increased by +$1.86 million (+20.45%).
- CKPT quarterly CFF is now -56.19% below its all-time high of $25.02 million, reached on September 30, 2020.
Performance
CKPT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$33.69 M
+$1.86 M+5.85%
September 30, 2024
Summary
- As of February 7, 2025, CKPT TTM cash flow from financing activities is $33.69 million, with the most recent change of +$1.86 million (+5.85%) on September 30, 2024.
- Over the past year, CKPT TTM CFF has dropped by -$3.66 million (-9.81%).
- CKPT TTM CFF is now -46.88% below its all-time high of $63.41 million, reached on June 30, 2021.
Performance
CKPT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CKPT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +171.7% | +20.4% | -9.8% |
| 3 y3 years | +29.5% | +987.5% | +180.6% |
| 5 y5 years | +41.6% | +10000.0% | +34.5% |
CKPT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.7% | -24.7% | >+9999.0% | -27.4% | +180.6% |
| 5 y | 5-year | at high | +171.7% | -56.2% | >+9999.0% | -46.9% | +180.6% |
| alltime | all time | -25.2% | +1920.4% | -56.2% | +593.3% | -46.9% | +1616.1% |
Checkpoint Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.96 M(<-9900.0%) | $33.69 M(+5.8%) |
| Jun 2024 | - | -$50.00 K(-100.4%) | $31.83 M(-31.4%) |
| Mar 2024 | - | $12.79 M(+28.0%) | $46.43 M(+14.8%) |
| Dec 2023 | $40.45 M(+171.7%) | $9.99 M(+9.8%) | $40.45 M(+8.3%) |
| Sep 2023 | - | $9.10 M(-37.5%) | $37.35 M(+27.7%) |
| Jun 2023 | - | $14.55 M(+113.7%) | $29.26 M(+90.6%) |
| Mar 2023 | - | $6.81 M(-1.2%) | $15.35 M(+3.1%) |
| Dec 2022 | $14.89 M(-63.0%) | $6.89 M(+583.5%) | $14.89 M(+24.0%) |
| Sep 2022 | - | $1.01 M(+57.0%) | $12.01 M(-4.3%) |
| Jun 2022 | - | $642.00 K(-89.9%) | $12.54 M(-44.7%) |
| Mar 2022 | - | $6.35 M(+58.3%) | $22.70 M(-43.6%) |
| Dec 2021 | $40.27 M(+28.9%) | $4.01 M(+160.1%) | $40.27 M(+0.8%) |
| Sep 2021 | - | $1.54 M(-85.7%) | $39.94 M(-37.0%) |
| Jun 2021 | - | $10.80 M(-54.8%) | $63.41 M(+14.8%) |
| Mar 2021 | - | $23.92 M(+550.5%) | $55.22 M(+76.7%) |
| Dec 2020 | $31.25 M | $3.68 M(-85.3%) | $31.25 M(-31.0%) |
| Sep 2020 | - | $25.02 M(+860.9%) | $45.31 M(+91.7%) |
| Jun 2020 | - | $2.60 M(-4750.0%) | $23.64 M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$56.00 K(-100.3%) | $25.04 M(-1.6%) |
| Dec 2019 | $25.45 M(-10.9%) | $17.75 M(+431.2%) | $25.45 M(+230.2%) |
| Sep 2019 | - | $3.34 M(-16.7%) | $7.71 M(-36.4%) |
| Jun 2019 | - | $4.01 M(+1030.4%) | $12.13 M(+50.0%) |
| Mar 2019 | - | $355.00 K(>+9900.0%) | $8.09 M(-71.7%) |
| Dec 2018 | $28.57 M(>+9900.0%) | $0.00(-100.0%) | $28.57 M(0.0%) |
| Sep 2018 | - | $7.76 M(<-9900.0%) | $28.57 M(+37.3%) |
| Jun 2018 | - | -$28.00 K(-100.1%) | $20.82 M(-0.1%) |
| Mar 2018 | - | $20.84 M(>+9900.0%) | $20.84 M(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2016 | -$2.22 M(-104.1%) | $0.00(0.0%) | -$2.22 M(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | -$2.22 M(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) | -$2.22 M(0.0%) |
| Mar 2016 | - | -$2.22 M | -$2.22 M |
| Dec 2015 | $54.05 M | - | - |
FAQ
- What is Checkpoint Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics annual CFF year-on-year change?
- What is Checkpoint Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics quarterly CFF year-on-year change?
- What is Checkpoint Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Checkpoint Therapeutics?
- What is Checkpoint Therapeutics TTM CFF year-on-year change?
What is Checkpoint Therapeutics annual cash flow from financing activities?
The current annual CFF of CKPT is $40.45 M
What is the all time high annual CFF for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high annual cash flow from financing activities is $54.05 M
What is Checkpoint Therapeutics annual CFF year-on-year change?
Over the past year, CKPT annual cash flow from financing activities has changed by +$25.56 M (+171.71%)
What is Checkpoint Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CKPT is $10.96 M
What is the all time high quarterly CFF for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high quarterly cash flow from financing activities is $25.02 M
What is Checkpoint Therapeutics quarterly CFF year-on-year change?
Over the past year, CKPT quarterly cash flow from financing activities has changed by +$1.86 M (+20.45%)
What is Checkpoint Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CKPT is $33.69 M
What is the all time high TTM CFF for Checkpoint Therapeutics?
Checkpoint Therapeutics all-time high TTM cash flow from financing activities is $63.41 M
What is Checkpoint Therapeutics TTM CFF year-on-year change?
Over the past year, CKPT TTM cash flow from financing activities has changed by -$3.66 M (-9.81%)